{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:31:27Z","timestamp":1768289487828,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.saa.2023.122836","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:42:38Z","timestamp":1683722558000},"page":"122836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Determination of Bendamustine, Gemcitabine and Vinorelbine (BEGEV) regimen in spiked human plasma using multivariate model update chemometric methods"],"prefix":"10.1016","volume":"299","author":[{"given":"Marco M.Z.","family":"Sharkawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-0848","authenticated-orcid":false,"given":"Norhan R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed T.","family":"El-Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha H.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2023.122836_b0005","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2008.18.7252","article-title":"Bendamustine: rebirth of an old drug","volume":"27","author":"Cheson","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.saa.2023.122836_b0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1200\/JCO.2012.45.3308","article-title":"Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma","volume":"31","author":"Moskowitz","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.saa.2023.122836_b0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/10428190801911704","article-title":"Current role of gemcitabine in the treatment of Hodgkin\u2019s lymphoma","volume":"49","author":"Yasuhiro","year":"2008","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.saa.2023.122836_b0020","first-page":"51","article-title":"High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease","volume":"64","author":"Bonfante","year":"2001","journal-title":"Eur. J. Haematol. Suppl."},{"key":"10.1016\/j.saa.2023.122836_b0025","first-page":"3293","volume":"34","author":"Santoro","year":"2016","journal-title":"Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: final results of a multicenter phase II study"},{"key":"10.1016\/j.saa.2023.122836_b0030","first-page":"1655","article-title":"Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an effective regimen for heavily pretreated, relapsed\/refractory Hodgkin lymphoma patients: a multicenter, retrospective real-world study, in","volume":"132","author":"Russo","year":"2018","journal-title":"American Society of Hematology Washington, DC"},{"key":"10.1016\/j.saa.2023.122836_b0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/bloodadvances.2019000984","article-title":"Five-year results of the BEGEV salvage regimen in relapsed\/refractory classical Hodgkin lymphoma","volume":"4","author":"Santoro","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.saa.2023.122836_b0040","first-page":"1696","article-title":"New Spectrophotometric Methods for the Determination of Bendamustine Hydrochloride-Nitrogen Mustard","volume":"4","author":"Annapurna","year":"2012","journal-title":"Drug Invention Today"},{"key":"10.1016\/j.saa.2023.122836_b0045","first-page":"139","article-title":"Derivative Spectrophotometric Methods for the Determination of Bendamustine Hydrochloride, Journal of Applied Pharmaceutical","volume":"2","author":"Annapurna","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.saa.2023.122836_b0050","first-page":"133","article-title":"A validated RP-HPLC method for the determination of bendamustine hydrochloride in tablet dosage form using gemcitabine hydrochloride as internal standard","volume":"37","author":"Katare","year":"2012","journal-title":"FABAD Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.saa.2023.122836_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jchromb.2014.04.027","article-title":"Simultaneous determination of bendamustine and its active metabolite, gamma-hydroxy-bendamustine in human plasma and urine using HPLC-fluorescence detector: application to a pharmacokinetic study in Chinese cancer patients","volume":"960","author":"Xie","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.122836_b0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0043-108124","article-title":"Sensitive LC-MS\/MS method for the simultaneous determination of Bendamustine and its active metabolite, \u03b3-hydroxybendamustine in small volume mice and dog plasma and its application to a pharmacokinetic study in mice and dogs","volume":"67","author":"Chandrashekar","year":"2017","journal-title":"Drug Research"},{"key":"10.1016\/j.saa.2023.122836_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchromb.2012.02.039","article-title":"Development and validation of LC\u2013MS\/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine","volume":"893","author":"Dubbelman","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.122836_b0070","first-page":"1102","article-title":"Spectrophotometric estimation of gemcitabine HCl in pharmaceutical dosage form via oxidative coupling reaction, Chem Sci","volume":"4","author":"Reddy","year":"2015","journal-title":"Transactions"},{"key":"10.1016\/j.saa.2023.122836_b0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.22159\/ijap.2017v9i5.19726","article-title":"Development and validation of UV-spectrophotometric methods for determination of gemcitabine hydrochloride in bulk and polymeric nanoparticles","volume":"9","author":"Kaur","year":"2017","journal-title":"Int J Appl Pharm"},{"key":"10.1016\/j.saa.2023.122836_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10337-022-04232-1","article-title":"FDA-Validated Ecofriendly Chromatographic Methods for Simultaneous Determination of Gemcitabine and Sorafenib: Applications to Pharmacokinetics","volume":"86","author":"Sharkawi","year":"2022","journal-title":"Chromatographia"},{"key":"10.1016\/j.saa.2023.122836_b0085","doi-asserted-by":"crossref","unstructured":"S. Borisagar, H. Patel, C. Patel, A validated stability-indicating HPTLC method for the estimation of gemcitabine HCl in its dosage form, JPC-Journal of Planar Chromatography-Modern TLC, 25 (2012) 77-80.","DOI":"10.1556\/JPC.25.2012.1.13"},{"key":"10.1016\/j.saa.2023.122836_b0090","doi-asserted-by":"crossref","unstructured":"C. Lanz, M. Fr\u00fch, W. Thormann, T. Cerny, B.H. Lauterburg, Rapid determination of gemcitabine in plasma and serum using reversed\u2010phase HPLC, Journal of separation science, 30 (2007) 1811-1820.","DOI":"10.1002\/jssc.200600534"},{"key":"10.1016\/j.saa.2023.122836_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpba.2017.12.048","article-title":"Ultra-sensitive LC\u2013MS\/MS method for the quantification of gemcitabine and its metabolite 2\u2032, 2\u2032-difluorodeoxyuridine in human plasma for a microdose clinical trial","volume":"151","author":"van Nuland","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.122836_b0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0378-4347(00)00354-6","article-title":"High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study","volume":"748","author":"Gauvin","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.saa.2023.122836_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.103982","article-title":"Quality by design based development and validation of HPLC method for simultaneous estimation of paclitaxel and vinorelbine tartrate in dual drug loaded liposomes","volume":"149","author":"Bonde","year":"2019","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.122836_b0110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jchromb.2011.01.039","article-title":"Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography\u2013tandem mass spectrometry and its pharmacokinetic application","volume":"879","author":"Qian","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.122836_b0115","doi-asserted-by":"crossref","DOI":"10.1039\/D3AY00081H","article-title":"Ecofriendly LC-MS\/MS and TLC-densitometric methods for simultaneous quantitative assay and monitoring of BEGEV regimen, in vivo pharmacokinetic study application","author":"Sharkawi","year":"2023","journal-title":"Anal. Methods"},{"key":"10.1016\/j.saa.2023.122836_b0120","doi-asserted-by":"crossref","first-page":"e3190","DOI":"10.1002\/cem.3190","article-title":"Comparison of two augmented classical least squares algorithms and PLS for determining nifuroxazide and its genotoxic impurities using UV spectroscopy","volume":"33","author":"Hegazy","year":"2019","journal-title":"J. Chemom."},{"key":"10.1016\/j.saa.2023.122836_b0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.5740\/jaoacint.17-0053","article-title":"Multivariate Validated Models for Simultaneous Determination of Ibuprofen and Famotidine in the Presence of Related Substances","volume":"101","author":"Elzanfaly","year":"2018","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2023.122836_b0130","article-title":"Tailoring Two Chemometric Models for Determination of Three Neuromuscular Combined Medications and Application to Spiked Human Plasma","author":"Abdelhamid","year":"2022","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2023.122836_b0135","series-title":"PLS-Toolbox2. 0 for use with Matlab\u00ae 6.5","author":"Wise","year":"1998"},{"key":"10.1016\/j.saa.2023.122836_b0140","series-title":"Chemometrics: data analysis for the laboratory and chemical plant","author":"Brereton","year":"2003"},{"key":"10.1016\/j.saa.2023.122836_b0145","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM) (2013) Bioanalytical Method Validation Guidance for Industry."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523005218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523005218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:34:32Z","timestamp":1761359672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142523005218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"alternative-id":["S1386142523005218"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2023.122836","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of Bendamustine, Gemcitabine and Vinorelbine (BEGEV) regimen in spiked human plasma using multivariate model update chemometric methods","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2023.122836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122836"}}